1Giskes, K, van Lenthe, F, Avendano-Pabon, M, et al. . (2011) A systematic review of environmental factors and obesogenic dietary intakes among adults: are we getting closer to understanding obesogenic environments? Obes Rev 12, e95–e106.
3Ogden, CL, Yanovski, SZ, Carroll, MD, et al. . (2007) The epidemiology of obesity. Gastroenterology 132, 2087–2102.
4Maury, E & Brichard, SM (2010) Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314, 1–16.
5Solomon, CG & Manson, JE (1997) Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr 66, 1044S–1050S.
6Hedley, AA, Ogden, CL, Johnson, CL, et al. . (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 291, 2847–2850.
8Maes, HH, Neale, MC & Eaves, LJ (1997) Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27, 325–351.
9Lane, MD & Tang, QQ (2005) From multipotent stem cell to adipocyte. Birth Defects Res A Clin Mol Teratol 73, 476–477.
10Clement, K, Vaisse, C, Lahlou, N, et al. . (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398–401.
11Gesta, S, Tseng, YH & Kahn, CR (2007) Developmental origin of fat: tracking obesity to its source. Cell 131, 242–256.
12Abate, N & Garg, A (1995) Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity. Prog Lipid Res 34, 53–70.
13Porter, SA, Massaro, JM, Hoffmann, U, et al. . (2009) Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 32, 1068–1075.
14Yusuf, S, Hawken, S, Ounpuu, S, et al. . (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364, 937–952.
15Haugen, F & Drevon, CA (2007) The interplay between nutrients and the adipose tissue. Proc Nutr Soc 66, 171–182.
16Ashton, KG (2002) Patterns of within-species body size variation of birds: strong evidence for Bergmann's rule. Global Ecol and Biogeogr 11, 505–523.
17Narvaez, CJ, Matthews, D, Broun, E, et al. . (2009) Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 150, 651–661.
18Guerre-Millo, M (2002) Adipose tissue hormones. J Endocrinol Invest 25, 855–861.
19Fliers, E & Boelen, A (2010) Type 2 deiodinase and brown fat: the heat is on – or off. Endocrinology 151, 4087–4089.
20Carafoli, E, Santella, L, Branca, D, et al. . (2001) Generation, control, and processing of cellular calcium signals. Crit Rev Biochem Mol Biol 36, 107–260.
21Sergeev, IN, Rhoten, WB & Spirichev, VB (1998) Vitamin D and intracellular calcium. Subcell Biochem 30, 271–297.
22Sergeev, IN (2005) Calcium signaling in cancer and vitamin D. J Steroid Biochem Mol Biol 97, 145–151.
23Sergeev, IN (2009) 1,25-Dihydroxyvitamin D3 induces Ca2+-mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem Biophys Res Commun 384, 18–21.
24Sergeev, IN & Norman, AW (2000) 1,25-Dihydroxyvitamin D3 and calcium signaling. In Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects, pp. 715–718 [Norman, AW, Bouillon, R and Thomasset, M, editors]. Riverside: University of California.
25Sergeev, IN & Rhoten, WB (1995) 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic β-cell line. Endocrinology 136, 2852–2861.
26Institute of Medicine (2011) Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press.
27United States Department of Agriculture (2010) Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010. Washington, DC: USDA.
28Scientific Panel on Dietetic Products, Nutrition and Allergies (2006) Tolerable Upper Intake Levels for Vitamins and Minerals. Scientific Committee on Food. Parma: European Food Safety Authority.
29Heaney, RP (2006) Calcium intake and disease prevention. Arq Bras Endocrinol Metabol 50, 685–693.
30Wright, JD, Wang, CY, Kennedy-Stephenson, J, et al. . (2003) Dietary intake of ten key nutrients for public health, United States: 1999–2000. Adv Data 334, 1–4.
32Pilvi, TK, Harala, S, Korpela, R, et al. . (2009) Effects of high-calcium diets with different whey proteins on weight loss and weight regain in high-fat-fed C57BL/6J mice. Br J Nutr 102, 337–341.
33Eller, LK & Reimer, RA (2010) A high calcium, skim milk powder diet results in a lower fat mass in male, energy-restricted, obese rats more than a low calcium, casein, or soy protein diet. J Nutr 140, 1234–1241.
34Parra, P, Bruni, G, Palou, A, et al. . (2008) Dietary calcium attenuation of body fat gain during high-fat feeding in mice. J Nutr Biochem 19, 109–117.
35de Wit, NJ, Bosch-Vermeulen, H, Oosterink, E, et al. . (2011) Supplementary dietary calcium stimulates faecal fat and bile acid excretion, but does not protect against obesity and insulin resistance in C57BL/6J mice. Br J Nutr 105, 1005–1011.
36Leite, LH & Sampaio, AB (2010) Dietary calcium, dairy food intake and metabolic abnormalities in HIV-infected individuals. J Hum Nutr Diet 23, 535–543.
37Dicker, D, Belnic, Y, Goldsmith, R, et al. . (2008) Relationship between dietary calcium intake, body mass index, and waist circumference in MABAT – the Israeli National Health and Nutrition Study. Isr Med Assoc J 10, 512–515.
38dos Santos, LC, de Padua Cintra, I, Fisberg, M, et al. . (2008) Calcium intake and its relationship with adiposity and insulin resistance in post-pubertal adolescents. J Hum Nutr Diet 21, 109–116.
39Palacios, C, Benedetti, P & Fonseca, S (2007) Impact of calcium intake on body mass index in Venezuelan adolescents. P R Health Sci J 26, 199–204.
40Gonzalez, AJ, White, E, Kristal, A, et al. . (2006) Calcium intake and 10-year weight change in middle-aged adults. J Am Diet Assoc 106, 1066–1073.
41Tidwell, DK & Valliant, MW (2011) Higher amounts of body fat are associated with inadequate intakes of calcium and vitamin D in African American women. Nutr Res 31, 527–536.
42Goldberg, TB, da Silva, CC, Peres, LN, et al. . (2009) Calcium intake and its relationship with risk of overweight and obesity in adolescents. Arch Latinoam Nutr 59, 14–21.
43Torres, MR, da Silva Ferreira, T, Carvalho, DC, et al. . (2010) Dietary calcium intake and its relationship with adiposity and metabolic profile in hypertensive patients. Nutrition 6, 666–671.
44Wagner, G, Kindrick, S, Hertzler, S, et al. . (2007) Effects of various forms of calcium on body weight and bone turnover markers in women participating in a weight loss program. J Am Coll Nutr 26, 456–461.
45Faghih, S, Abadi, AR, Hedayati, M, et al. . (2011) Comparison of the effects of cows’ milk, fortified soy milk, and calcium supplement on weight and fat loss in premenopausal overweight and obese women. Nutr Metab Cardiovasc Dis 21, 499–503.
46Teegarden, D, White, KM, Lyle, RM, et al. . (2008) Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 16, 1566–1572.
47Riedt, CS, Schlussel, Y, von Thun, N, et al. . (2007) Premenopausal overweight women do not lose bone during moderate weight loss with adequate or higher calcium intake. Am J Clin Nutr 85, 972–980.
48Thomas, DT, Wideman, L & Lovelady, CA (2010) Effects of calcium and resistance exercise on body composition in overweight premenopausal women. J Am Coll Nutr 29, 604–611.
49Yanovski, JA, Parikh, SJ, Yanoff, LB, et al. . (2009) Effects of calcium supplementation on body weight and adiposity in overweight and obese adults: a randomized trial. Ann Intern Med 150, 821–829.
50Chailurkit, LO, Saetung, S, Thakkinstian, A, et al. . (2010) Discrepant influence of vitamin D status on parathyroid hormone and bone mass after two years of calcium supplementation. Clin Endocrinol (Oxf) 73, 167–172.
51Trowman, R, Dumville, JC, Hahn, S, et al. . (2006) A systematic review of the effects of calcium supplementation on body weight. Br J Nutr 95, 1033–1038.
52Torres, MR, Francischetti, EA, Genelhu, V, et al. . (2010) Effect of a high-calcium energy-reduced diet on abdominal obesity and cardiometabolic risk factors in obese Brazilian subjects. Int J Clin Pract 64, 1076–1083.
53Norman, AW (1979) Vitamin D: The Calcium Homeostatic Steroid Hormone. New York: Academic Press.
54Spirichev, VB & Sergeev, IN (1988) Vitamin D: experimental research and its practical application. World Rev Nutr Diet 56, 173–216.
55Sergeev, IN, Rhoten, WB & Norman, AW (1997) 1,25-Dihydroxyvitamin D3, intracellular Ca2+ and apoptosis in breast cancer cells. In Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, pp. 473–474 [Norman, AW, Bouillon, R and Thomasset, M, editors]. Riverside: University of California.
56Sergeev, IN & Rhoten, WB (1998) Regulation of intracellular calcium in human breast cancer cells. Endocrine 9, 321–327.
57Norman, AW, Nemere, I, Zhou, LX, et al. . (1992) 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 41, 231–240.
58Sergeev, IN (2009) Novel mediators of vitamin D signaling in cancer and obesity. Immunol Endocr Metab Agents Med Chem 9, 153–158.
59Nemere, I, Garbi, N, Hammerling, GJ, et al. . (2010) Intestinal cell calcium uptake and the targeted knockout of the 1,25D3-MARRS (membrane-associated, rapid response steroid-binding) receptor/PDIA3/Erp57. J Biol Chem 285, 31859–31866.
60Nemere, I & Hintze, K (2008) Novel hormone “receptors”. J Cell Biochem 103, 401–407.
61Sergeev, IN & Spirichev, VB (1989) Are the receptors of 1,25-dihydroxyvitamin D3 vitamin K dependent? Biochemistry (Mosc) 54, 1325–1330.
62Norman, AW, Sergeev, IN, Bishop, JE, et al. . (1993) Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues. Cancer Res 53, 3935–3942.
63Farach-Carson, MC, Sergeev, IN & Norman, AW (1991) Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure–function studies using ligand analogs. Endocrinology 129, 1876–1884.
64Norman, AW & Silva, FR (2001) Structure function studies: identification of vitamin D analogs for the ligand-binding domains of important proteins in the vitamin D–endocrine system. Rev Endocr Metab Disord 2, 229–238.
65Sergeev, IN (2004) Calcium as a mediator of 1,25-dihydroxyvitamin D3-induced apoptosis. J Steroid Biochem Mol Biol 89–90, 419–425.
66Sergeev, IN & Rhoten, WB (1998) Intracellular calcium, the vitamin D hormone and apoptosis in breast cancer cells. Mol Biol Cell 9, 251a.
67Sergeev, IN, Rhoten, WB & Carney, MD (1996) Calbindins decreased after space flight. Endocrine 5, 335–340.
68Sergeev, IN & Rhoten, WB (1995) Video imaging of calcium and pH in breast-cancer cells. Mol Biol Cell 6, 2039.
69Rhoten, WB & Sergeev, IN (1994) Calbindin-D28k appears to buffer intracellular Ca2+ in butyrate-treated rat insulinoma cells. Endocrine 2, 989–995.
70Sergeev, IN & Spirichev, VB (1988) The role of vitamin K in the interaction of 1,25-dihydroxyvitamin D3 receptors with DNA (article in Russian). Biull Eksp Biol Med 106, 695–698.
71Sergeev, IN & Norman, AW (1992) Vitamin-K-dependent γ-carboxylation of the 1,25-dihydroxyvitamin-D3 receptor. Biochem Biophys Res Commun 189, 1543–1547.
72Holick, MF (1997) Photobiology of vitamin D. In Vitamin D, pp. 33–39 [Feldman, D, Glorieux, FH and Pike, JW, editors]. San Diego: Academic Press.
73Verreault, R, Semba, RD, Volpato, S, et al. . (2002) Low serum vitamin D does not predict new disability or loss of muscle strength in older women. J Am Geriatr Soc 50, 912–917.
74Norman, AW & Bouillon, R (2010) Vitamin D nutritional policy needs a vision for the future. Exp Biol Med 235, 1034–1045.
75Foss, YJ (2009) Vitamin D deficiency is the cause of common obesity. Med Hypotheses 72, 314–321.
76Rosenstreich, SJ, Rich, C & Volwiler, W (1971) Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat. J Clin Invest 50, 679–687.
77Zemel, MB, Shi, H, Greer, B, et al. . (2000) Regulation of adiposity by dietary calcium. FASEB J 14, 1132–1138.
78Aasheim, ET, Hofso, D, Hjelmesaeth, J, et al. . (2008) Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 87, 362–369.
79Alemzadeh, R, Kichler, J, Babar, G, et al. . (2008) Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 57, 183–191.
80Ardawi, MS, Qari, MH, Rouzi, AA, et al. . (2011) Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporos Int 22, 463–475.
81Beydoun, MA, Boueiz, A, Shroff, MR, et al. . (2010) Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States. J Clin Endocrinol Metab 95, 3814–3827.
82Brock, K, Huang, WY, Fraser, DR, et al. . (2010) Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J Steroid Biochem Mol Biol 121, 462–466.
83Elizondo-Montemayor, L, Ugalde-Casas, PA, Serrano-Gonzalez, M, et al. . (2010) Serum 25-hydroxyvitamin D concentration, life factors and obesity in Mexican children. Obesity (Silver Spring) 18, 1805–1811.
84Herranz Antolin, S, Garcia Martinez Mdel, C & Alvarez De Frutos, V (2010) Vitamin D deficiency in morbidly obese patients. A case–control study. Endocrinol Nutr 57, 256–261.
85Hypponen, E & Power, C (2006) Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 29, 2244–2246.
86Konradsen, S, Ag, H, Lindberg, F, et al. . (2008) Serum 1,25-dihydroxyvitamin D is inversely associated with body mass index. Eur J Nutr 47, 87–91.
87Kremer, R, Campbell, PP, Reinhardt, T, et al. . (2009) Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab 94, 67–73.
88Lagunova, Z, Porojnicu, AC, Lindberg, F, et al. . (2009) The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 29, 3713–3720.
89Reinehr, T, de Sousa, G, Alexy, U, et al. . (2007) Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 157, 225–232.
90Smotkin-Tangorra, M, Purushothaman, R, Gupta, A, et al. . (2007) Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab 20, 817–823.
91Valina-Toth, AL, Lai, Z, Yoo, W, et al. . (2010) Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans. Clin Endocrinol (Oxf) 72, 595–603.
92Vilarrasa, N, Maravall, J, Estepa, A, et al. . (2007) Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 30, 653–658.
93Yanoff, LB, Parikh, SJ, Spitalnik, A, et al. . (2006) The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese black Americans. Clin Endocrinol (Oxf) 64, 523–529.
94Adam, MA, Untch, BR, Danko, ME, et al. . (2010) Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism. J Clin Endocrinol Metab 95, 4917–4924.
95Johnson, LK, Hofsø, D, Aasheim, ET, et al. . (2012) Impact of gender on vitamin D deficiency in morbidly obese patients: a cross-sectional study. Eur J Clin Nutr 66, 83–90.
96Pacifico, L, Anania, C, Osborn, JF, et al. . (2011) Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol 165, 603–611.
97Renzaho, AM, Halliday, JA & Nowson, C (2011) Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: a systematic review. Nutrition 27, 868–879.
98Vashi, PG, Lammersfeld, CA, Braun, DP, et al. . (2011) Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer. Nutr J 10, 51.
99Rajakumar, K, de las Heras, J, Chen, TC, et al. . (2011) Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab 96, 1560–1567.
100Lagunova, Z, Porojnicu, AC, Lindberg, FA, et al. . (2011) Vitamin D status in Norwegian children and adolescents with excess body weight. Pediatr Diabetes 12, 120–126.
101World Health Organization (2000) Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation, WHO Technical Report Series no. 894. Geneva: WHO.
102Sharma, S, Barr, AB, Macdonald, HM, et al. . (2011) Vitamin D deficiency and disease risk among aboriginal Arctic populations. Nutr Rev 69, 468–478.
103Mawer, EB, Backhouse, J, Holman, CA, et al. . (1972) The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 43, 413–431.
104Zittermann, A, Frisch, S, Berthold, HK, et al. . (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89, 1321–1327.
105Sneve, M, Figenschau, Y & Jorde, R (2008) Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 159, 675–684.
106Major, GC, Alarie, F, Dore, J, et al. . (2007) Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 85, 54–59.
107Holecki, M, Zahorska-Markiewicz, B, Wiecek, A, et al. . (2008) Influence of calcium and vitamin D supplementation on weight and fat loss in obese women. Obes Facts 1, 274–279.
108Zhou, J, Zhao, LJ, Watson, P, et al. . (2010) The effect of calcium and vitamin D supplementation on obesity in postmenopausal women: secondary analysis for a large-scale, placebo controlled, double-blind, 4-year longitudinal clinical trial. Nutr Metab (Lond) 7, 62.
109Caan, B, Neuhouser, M, Aragaki, A, et al. . (2007) Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med 167, 893–902.
110Buchowski, MS, Aslam, M, Dossett, C, et al. . (2010) Effect of dairy and non-dairy calcium on fecal fat excretion in lactose digester and maldigester obese adults. Int J Obes (Lond) 34, 127–135.
111Christensen, R, Lorenzen, JK, Svith, CR, et al. . (2009) Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev 10, 475–486.
112Reed, JC (2002) Apoptosis-based therapies. Nat Rev Drug Discov 1, 111–121.
113Prins, JB & O'Rahilly, S (1997) Regulation of adipose cell number in man. Clin Sci (Lond) 92, 3–11.
114Berridge, MJ, Bootman, MD & Lipp, P (1998) Calcium – a life and death signal. Nature 395, 645–648.
115Orrenius, S, Zhivotovsky, B & Nicotera, P (2003) Regulation of cell death: the calcium–apoptosis link. Nat Rev Mol Cell Biol 4, 552–565.
116Sergeev, IN, Colby, J & Norman, AW (2000) 1,25-Dihydroxyvitamin D3 triggers calcium-mediated apoptosis in breast cancer cells. In Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects, pp. 399–402 [Norman, AW, Bouillon, R and Thomasset, M, editors]. Riverside: University of California.
117Mathiasen, IS, Sergeev, IN, Bastholm, L, et al. . (2002) Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J Biol Chem 277, 30738–30745.
118Sergeev, IN & Norman, AW (2003) Calcium as a mediator of apoptosis in bovine oocytes and preimplantation embryos. Endocrine 22, 169–176.
119McConkey, DJ & Orrenius, S (1997) The role of calcium in the regulation of apoptosis. Biochem Biophys Res Commun 239, 357–366.
120Welsh, J, VanWeelden, K, Flanagan, L, et al. . (1998) The role of vitamin D3 and antiestrogens in modulating apoptosis of breast cancer cells and tumors. Subcell Biochem 30, 245–270.
121Carafoli, E & Molinari, M (1998) Calpain: a protease in search of a function? Biochem Biophys Res Commun 247, 193–203.
122Ho, PK & Hawkins, CJ (2005) Mammalian initiator apoptotic caspases. FEBS J 272, 5436–5453.
123Oubrahim, H, Chock, PB & Stadtman, ER (2002) Manganese(II) induces apoptotic cell death in NIH3T3 cells via a caspase-12-dependent pathway. J Biol Chem 277, 20135–20138.
124Nakagawa, T, Zhu, H, Morishima, N, et al. . (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403, 98–103.
125Welsh, J & Byrne, B (2007) Identification of novel mediators of vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells. J Steroid Biochem Mol Biol 103, 703–707.
126Sergeev, IN, Li, S, Ho, CT, et al. . (2009) Polymethoxyflavones activate Ca2+-dependent apoptotic targets in adipocytes. J Agric Food Chem 57, 5771–5776.
127Sergeev, IN, Ho, CT, Li, S, et al. . (2007) Apoptosis-inducing activity of hydroxylated polymethoxyflavones and polymethoxyflavones from orange peel in human breast cancer cells. Mol Nutr Food Res 51, 1478–1484.
128Sergeev, IN, Li, S, Colby, J, et al. . (2006) Polymethoxylated flavones induce Ca2+-mediated apoptosis in breast cancer cells. Life Sci 80, 245–253.
129Kong, J & Li, YC (2006) Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 290, E916–E924.
130Jones, JR, Barrick, C, Kim, KA, et al. . (2005) Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A 102, 6207–6212.
131Clarke, SL, Robinson, CE & Gimble, JM (1997) CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor γ2 promoter. Biochem Biophys Res Commun 240, 99–103.
132Blumberg, JM, Tzameli, I, Astapova, I, et al. . (2006) Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem 281, 11205–11213.
133Zemel, MB & Sun, X (2008) Calcitriol and energy metabolism. Nutr Rev 66, S139–S146.
134Sampath, V, Havel, PJ & King, JC (2008) Calcium supplementation does not alter lipid oxidation or lipolysis in overweight/obese women. Obesity (Silver Spring) 16, 2400–2404.
135Bortolotti, M, Rudelle, S, Schneiter, P, et al. . (2008) Dairy calcium supplementation in overweight or obese persons: its effect on markers of fat metabolism. Am J Clin Nutr 88, 877–885.
136Nedergaard, J, Ricquier, D & Kozak, LP (2005) Uncoupling proteins: current status and therapeutic prospects. EMBO Rep 6, 917–921.
137Sun, X & Zemel, MB (2004) Role of uncoupling protein 2 (UCP2) expression and 1α, 25-dihydroxyvitamin D3 in modulating adipocyte apoptosis. FASEB J 18, 1430–1432.